Alyeska Investment Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-262,105	Closed	-$3.34M	–	504
2017 Q4	$3.34M	Hold	262,105	–	–	0.03%	262
2017 Q3	$4.08M	Buy	262,105 +79,683	+44%	+$1.24M	0.03%	286
2017 Q2	$2.56M	Buy	182,422 +44,866	+33%	+$629K	0.02%	308
2017 Q1	$3.03M	Buy	+137,556	New	+$3.03M	0.02%	350